Literature DB >> 23993979

Molecular cloning, overexpression, and an efficient one-step purification of α5β1 integrin.

Lawrence J Tartaglia1, Antonette Bennett, Alexander S Plattner, Nicholas Muzyczka, Chen Ling, Arun Srivastava, Mavis Agbandje-McKenna.   

Abstract

The α5β1 integrin heterodimer is involved in many cellular processes and is an anti-cancer therapeutic target. Therefore, access to quantities of protein suitable for studies aimed at understanding its biological functions is important. To this end, a large-scale protein expression system, utilizing the recombinant baculovirus/SF9 insect cell expression system, was created to produce the extracellular domain of the α5β1 integrin. An incorporated 8X-histidine tag enabled one-step nickel-column purification. Following sequence confirmation by LC-MS/MS, the conformation of the heterodimer was characterized by native dot blot and negative stain electron microscopy. Cellular transduction inhibition studies confirmed biological activity. The system allows expression and purification of α5β1 integrin in quantities suitable for an array of different experiments including structural biology.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Electron microscopy; Recombinant baculovirus; pFastBac1 vector; α5β1 Integrin expression

Mesh:

Substances:

Year:  2013        PMID: 23993979      PMCID: PMC3873862          DOI: 10.1016/j.pep.2013.08.013

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  28 in total

1.  Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search.

Authors:  Andrew Keller; Alexey I Nesvizhskii; Eugene Kolker; Ruedi Aebersold
Journal:  Anal Chem       Date:  2002-10-15       Impact factor: 6.986

2.  Optimized production of high-titer recombinant adeno-associated virus in roller bottles.

Authors:  Y L Liu; K Wagner; N Robinson; D Sabatino; P Margaritis; W Xiao; R W Herzog
Journal:  Biotechniques       Date:  2003-01       Impact factor: 1.993

3.  Alpha5beta1-integrin controls ebolavirus entry by regulating endosomal cathepsins.

Authors:  Kathryn L Schornberg; Charles J Shoemaker; Derek Dube; Michelle Y Abshire; Sue E Delos; Amy H Bouton; Judith M White
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-28       Impact factor: 11.205

4.  Cell-autonomous requirement for beta1 integrin in endothelial cell adhesion, migration and survival during angiogenesis in mice.

Authors:  Timothy R Carlson; Huiqing Hu; Rickmer Braren; Yung Hae Kim; Rong A Wang
Journal:  Development       Date:  2008-05-14       Impact factor: 6.868

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Initial signaling of the fibronectin receptor (alpha5beta1 integrin) in hepatic stellate cells is independent of tyrosine phosphorylation.

Authors:  M T Milliano; B A Luxon
Journal:  J Hepatol       Date:  2003-07       Impact factor: 25.083

7.  Regulation of the fibronectin receptor affinity by divalent cations.

Authors:  J Gailit; E Ruoslahti
Journal:  J Biol Chem       Date:  1988-09-15       Impact factor: 5.157

8.  Integrin signaling in cancer cell survival and chemoresistance.

Authors:  Fawzi Aoudjit; Kristiina Vuori
Journal:  Chemother Res Pract       Date:  2012-04-11

9.  Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin.

Authors:  E L George; E N Georges-Labouesse; R S Patel-King; H Rayburn; R O Hynes
Journal:  Development       Date:  1993-12       Impact factor: 6.868

10.  Integrin α5β1, the Fibronectin Receptor, as a Pertinent Therapeutic Target in Solid Tumors.

Authors:  Florence Schaffner; Anne Marie Ray; Monique Dontenwill
Journal:  Cancers (Basel)       Date:  2013-01-15       Impact factor: 6.639

View more
  1 in total

Review 1.  Research advances on structure and biological functions of integrins.

Authors:  Li Pan; Yuan Zhao; Zhijie Yuan; Guixin Qin
Journal:  Springerplus       Date:  2016-07-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.